| Authors: |
Ataç T; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Hansen JS; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Novo Nordisk Foundation Initiative for Vaccines and Immunity, NIVI Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark., Isling LK; Center for Vaccine Research, Department of Vaccine Development, Statens Serum Institut, Copenhagen, Denmark., Pedersen GK; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Initiative for Vaccines and Immunity, NIVI Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark., Wørzner K; Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark; Novo Nordisk Foundation Initiative for Vaccines and Immunity, NIVI Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark. Electronic address: kawo@ssi.dk. |
